PrintyMed: Funding, Investors & Team (Sep 2026)
PrintyMed is a breakthrough medicine company that specializes in the creation of artificial spider silk for a variety of medical purposes. Despite the well-known applications of artificial spider silk, our team of scientists, engineers, and medical professionals is collaborating to develop a material that can be used to 3D print living tissue. This novel approach to medicine has the potential to transform the medical industry and improve the lives of millions. We are thrilled to be at the vanguard of this new technology, continually pushing the limits of what is possible.
PrintyMed has raised $590k across 2 funding rounds on record, the most recent an undisclosed round of $590k announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PrintyMed Company Profile and Key Stats
Latest funding round on record: May 2026.
PrintyMed Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
PrintyMed announced an undisclosed round in Apr 2026; the amount was not disclosed.
1 month later, an undisclosed round of $590k was announced in May 2026.
PrintyMed Founders and Leadership Team
No contact details are on record for this team yet.
PrintyMed Funding Compared to Other Biotechnology Startups
PrintyMed's latest round of $590k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PrintyMed in Biotechnology and Riga
Companies Similar to PrintyMed
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
PrintyMed Funding FAQs
What does PrintyMed do?
PrintyMed is a breakthrough medicine company that specializes in the creation of artificial spider silk for a variety of medical purposes. Despite the well-known applications of artificial spider silk, our team of scientists, engineers, and medical professionals is collaborating to develop a material that can be used to 3D print living tissue. This novel approach to medicine has the potential to transform the medical industry and improve the lives of millions. We are thrilled to be at the vanguard of this new technology, continually pushing the limits of what is possible.
How much funding has PrintyMed raised?
PrintyMed has raised $590k across 2 rounds on record. The most recent is an undisclosed round of $590k announced in May 2026.
When did PrintyMed last raise funding?
PrintyMed's most recent funding round on record is an undisclosed round of $590k, announced in May 2026.
Who founded PrintyMed?
FundedIQ lists Jekaterina Romanova (Founder) at PrintyMed.
Where is PrintyMed headquartered?
PrintyMed is based in Riga, Riga, Latvia.
How many employees does PrintyMed have?
PrintyMed is in the 1-10 employee band.
How does PrintyMed's funding compare to other Biotechnology startups?
PrintyMed's latest round of $590k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's PrintyMed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PrintyMed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.